Desymmetrization of meso -Anhydride Enabled Enantioselective Synthesis of (−)-7-(Bromomethylene)-3-amidobicyclo2.2.1heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery Synthesis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Enantioselective synthesis achieves >99% ee in scaffold for drug discovery, suggesting new pathways in medicinal chemistry.

Synthesis yielded a drug scaffold with greater than 99% enantiomeric excess, indicating high precision in drug design.
Key steps included Diels-Alder reaction with maleic anhydride and quinidine-mediated desymmetrization, achieving >93% ee for hydroxyl groups.
Utilization of chiral resolution together with Curtius rearrangement and Swern oxidation enabled efficient compound formation.
This method highlights the potential for creating complex drug structures via advanced synthetic techniques.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Enantioselective synthesis achieves >99% ee in scaffold for drug discovery, suggesting new pathways in medicinal chemistry.

Synthesis yielded a drug scaffold with greater than 99% enantiomeric excess, indicating high precision in drug design.
Key steps included Diels-Alder reaction with maleic anhydride and quinidine-mediated desymmetrization, achieving >93% ee for hydroxyl groups.
Utilization of chiral resolution together with Curtius rearrangement and Swern oxidation enabled efficient compound formation.
This method highlights the potential for creating complex drug structures via advanced synthetic techniques.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark